Category guide

Weight-loss injections in South Africa

  • Home
  • Weight-loss injections

“Weight-loss injections” almost always means GLP-1 receptor agonists — medicines first developed for type 2 diabetes that turned out to be the most effective non-surgical weight-loss treatments we have. Here's an honest, South-African overview.

Medically reviewed by an HPCSA-registered doctor Last updated 8 sources

The short answer

Weight-loss injections are weekly (or daily) shots of a GLP-1 medicine. In South Africa the main options are Ozempic and Wegovy (both semaglutide), Mounjaro (tirzepatide) and Saxenda (liraglutide). They typically cost R2 700–R5 000+ a month at maintenance and are prescription-only. Medical aids rarely cover them for weight loss. In trials, average weight loss ranges from about 8% (Saxenda) to over 20% (Mounjaro), alongside diet and exercise.

Avoid counterfeits

SAHPRA has warned about falsified semaglutide circulating in South Africa. Only use products dispensed by a licensed pharmacy on a valid prescription, and be wary of anything sold on social media, by couriers without a script, or at prices that look too good. See our compounded & counterfeit guide.

What “weight-loss injections” actually are

The injections everyone is talking about belong to a class called GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after eating; these medicines mimic it, which reduces appetite, slows stomach emptying and steadies blood sugar. The practical effect is a quieter appetite and less “food noise”. Tirzepatide (Mounjaro) adds a second hormone receptor (GIP), which is part of why it tends to produce the largest average weight loss. See how GLP-1 works.

They are not fat-burners or a substitute for eating well and moving — they work with diet and activity, and most of the benefit fades if you stop.

The medicines available in South Africa

Two of these share an active ingredient: Ozempic and Wegovy are both semaglutide; Mounjaro is tirzepatide; Saxenda is liraglutide. Tap a medicine for its full SA guide.

Ozempic

Semaglutide
R2 700–R3 300/mo

Read more

Mounjaro

Tirzepatide
R3 500–R4 600/mo

Read more

Wegovy

Semaglutide (higher weight-loss doses)
R1 900–R3 750/mo

Read more

Saxenda

Liraglutide
R2 800–R4 800/mo

Read more

How well they work

These are the most effective weight-loss medicines ever marketed, but results vary between people. Average weight loss in the major trials, on top of lifestyle changes, was roughly:

  • Saxenda (liraglutide): ~8% over 56 weeks (SCALE).
  • Wegovy / Ozempic (semaglutide): ~15% at 2.4 mg (STEP 1).
  • Mounjaro (tirzepatide): up to ~21–22.5% at the top dose (SURMOUNT-1).

Trial averages are not promises — some people lose much more, some much less. We never publish guarantees. See the full comparison.

Side effects & safety

The common side effects are gastrointestinal — nausea, constipation, diarrhoea, reflux — usually worst when you start or step up a dose, and easing with time and slow titration. Less common but serious risks include pancreatitis and gallbladder problems, with specific cautions for certain thyroid conditions. These medicines aren't for use in pregnancy. Our side effects guide covers management in detail.

When to seek help

Seek urgent help for severe, persistent abdominal pain (especially radiating to the back), signs of an allergic reaction, or persistent vomiting with dehydration.

What they cost in South Africa

At a typical maintenance dose, expect roughly:

Indicative monthly retail prices in Rand · June 2026 · excludes consultation & labs
MedicineDose Typical / monthNote
OzempicSemaglutide0.25 mg / 0.5 mg (starting)R1,400 – R1,500One pen lasts ~4 weeks at low doses.
OzempicSemaglutide1 mg (common maintenance)R2,700 – R3,300Most-prescribed maintenance dose.
OzempicSemaglutide2 mg (highest)R3,500 – R6,000May need more than one pen per month.
WegovySemaglutide0.25 mg (starting)R1,800 – R1,900Prices fell after the March 2026 cut.
WegovySemaglutide1.0 – 1.7 mgR2,400 – R3,200Titration phase.
WegovySemaglutide2.4 mg (maintenance)R3,400 – R3,800Full weight-management dose.
MounjaroTirzepatide2.5 / 5 mgR3,500 – R3,900Roughly R880–R1,000 per vial/pen, ~4 a month.
MounjaroTirzepatide7.5 / 10 mgR4,200 – R4,600Maintenance range.
MounjaroTirzepatide12.5 / 15 mgR4,600 – R5,200Highest doses; availability varies.
SaxendaLiraglutide0.6 → 1.8 mg (titration)R2,700 – R3,000Per 6 mg/mL pen (~R2,727).
SaxendaLiraglutide3.0 mg (full daily dose)R4,400 – R4,800Needs several pens a month at full dose.

Prices vary by pharmacy (Clicks, Dis-Chem, Medirite) and change often, and there are hidden costs — the consultation, blood tests, needles and cold-chain delivery.

Does medical aid cover them?

Generally not for weight loss. Obesity isn't a Prescribed Minimum Benefit, so most schemes don't fund these as a chronic benefit. Some plans allow payment from a medical savings account, and Ozempic may be covered under a chronic benefit if you have type 2 diabetes. See medical-aid cover.

Who they're for

Clinicians generally consider these medicines for adults with a BMI of 30+, or 27+ with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea — as part of a broader plan, not a quick fix. Check the thresholds in am I eligible? or try the private BMI calculator.

How to get one safely

These are Schedule 4 medicines — you need a prescription from a registered doctor, and you should only get the medicine from a licensed pharmacy. The usual routes are an in-person GP or a reputable telehealth provider (online scripts from around R250), with the medicine dispensed or couriered under cold chain. Avoid anyone selling these without a prescription — SAHPRA has warned about falsified semaglutide.

Frequently asked questions

There's no single “best” — it depends on your goals, budget, availability and health. On average weight loss, tirzepatide (Mounjaro) leads, then semaglutide (Wegovy/Ozempic), then liraglutide (Saxenda). See our balanced comparison.

No. They are Schedule 4 prescription medicines. A registered provider must assess you and issue a prescription, dispensed by a licensed pharmacy.

Trial averages range from about 8% to over 20% of body weight depending on the medicine, but individual results vary widely. We don't publish guarantees.

Often not fully. Studies show meaningful regain after stopping, which is why these are usually long-term treatments alongside lifestyle change.

Sources & references

We cite primary sources and paraphrase them. Last reviewed June 2026. See our editorial policy and full sources hub.

  1. 1SAHPRA — registered health products & safety alertsSouth African Health Products Regulatory Authority. SA registration status of medicines and counterfeit / falsified-product warnings.
  2. 2STEP programme — semaglutide for weight managementNew England Journal of Medicine (Wilding et al., STEP 1, 2021). Average weight loss with semaglutide 2.4 mg (~15% at 68 weeks).
  3. 3SURMOUNT-1 — tirzepatide for weight managementNew England Journal of Medicine (Jastreboff et al., 2022). Average weight loss with tirzepatide (up to ~21–22.5% at highest dose).
  4. 4SURMOUNT-5 — tirzepatide vs semaglutide head-to-headNew England Journal of Medicine (Aronne et al., 2025). Direct comparison favouring tirzepatide (~20.2% vs 13.7% weight loss).
  5. 5SCALE — liraglutide (Saxenda) for weight managementNew England Journal of Medicine (Pi-Sunyer et al., 2015). Average weight loss with liraglutide 3.0 mg (~8%).
  6. 6Which breakthrough weight-loss medicines can you get in SA?Spotlight. SA availability and registration context for GLP-1 medicines.
  7. 7Weight-loss drugs are no quick fix / Chronic Illness BenefitDiscovery Health. Medical-aid funding context and chronic-benefit criteria.
  8. 8SA Medicine Price Registry (SEP database)National Department of Health. Single Exit Price reference for medicines sold in SA.
Next step

Not sure where to start?

A registered provider can talk you through the options, check whether treatment is appropriate, and start you safely on a genuine product.

Book a consultation → Registered providers · genuine medicines · licensed pharmacies